Clinical Trial Update: Tolerance Study of the Dietary Supplement Valedia [Phase 1]

View source ↗

Summary

A Phase 1 tolerance study of the dietary supplement Valedia in overweight individuals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Valedia

Snippet

Sponsor: Valbiotis | Conditions: Overweight | Phase 1 | Status: COMPLETED